Platelet activation in patients with colorectal cancer
Authors:
- V. CarnevaleVCV. Carnevale
- P. PatrignaniPPP. Patrignani
- 1 February 2005
- journal article
- clinical trial
- Published by Elsevier in Prostaglandins, Leukotrienes and Essential Fatty Acids
- Vol. 72 (2) , 79-83
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- COX-2 and beyond: approaches to prostaglandin inhibition in human diseaseNature Reviews Drug Discovery, 2003
- A Randomized Trial of Aspirin to Prevent Colorectal AdenomasNew England Journal of Medicine, 2003
- A Randomized Trial of Aspirin to Prevent Colorectal Adenomas in Patients with Previous Colorectal CancerNew England Journal of Medicine, 2003
- Cyclooxygenase 2 Promotes Cell Survival by Stimulation of Dynein Light Chain Expression and Inhibition of Neuronal Nitric Oxide Synthase ActivityMolecular and Cellular Biology, 2000
- The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous PolyposisNew England Journal of Medicine, 2000
- Adhesive receptors expressed by tumor cells and platelets: novel targets for therapeutic anti-metastatic strategiesMedical Oncology, 1995
- Inhibition of NF-κB by Sodium Salicylate and AspirinScience, 1994
- Platelets and cancer metastasis: A causal relationship?Cancer and Metastasis Reviews, 1992
- Radioimmunoassay of 11-dehydrothromboxane B2 in human plasma and urineBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1987
- Dose-Related Kinetics of AspirinNew England Journal of Medicine, 1984